drugset / Trial / NCT00471029

Compare Efficacy of Gastric Acid Suppression by Oral and Intravenous Administration of Esomeprazole in Patients With Peptic Ulcer

NCT00471029

Phase 4 Unknown 20 enrolled Pamela Youde Nethersole Eastern Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to compare the gastric acid suppression profile among different regimen (Oral Vs Intravenous)of administration of proton pump inhibitor - Esomeprazole by 24hours intragastric pH monitoring.

Timeline

Start
2005-09
Primary completion
Completion
2007-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Esomeprazole Small molecule 8 mg Intravenous
Subject Esomeprazole Small molecule 40 mg Intravenous

Indications